← Browse by Condition
Medical Condition

wilms tumor

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for wilms tumor sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — wilms tumor Clinical Trials

How many clinical trials are currently recruiting for wilms tumor?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for wilms tumor, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for wilms tumor?
wilms tumor research spans Phase 1 (5 trials), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a wilms tumor clinical trial?
Eligibility criteria for wilms tumor trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
5
Phase 2
1
Top Sponsors
Sun Yat-sen University 1 trial
Children's National Research Institute 1 trial
New York Medical College 1 trial
St. Jude Children's Research Hospital 1 trial
Centre Oscar Lambret 1 trial

Recruiting Clinical Trials

NCT07584499 Phase 1
Recruiting
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
Enrollment
51 pts
Location
China
Sponsor
Sun Yat-sen University
View Trial →
NCT07172958 Phase 1
Recruiting
Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
Enrollment
18 pts
Location
United States
Sponsor
Children's National Research I...
View Trial →
NCT04308330 Phase 1
Recruiting
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
Enrollment
30 pts
Location
United States
Sponsor
New York Medical College
View Trial →
NCT04897321 Phase 1
Recruiting
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Enrollment
48 pts
Location
United States
Sponsor
St. Jude Children's Research H...
View Trial →
NCT05384821 Phase 1, Phase 2
Recruiting
Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)
Enrollment
28 pts
Location
France
Sponsor
Centre Oscar Lambret
View Trial →

Related Conditions

rhabdomyosarcoma (4) neuroblastoma (4) ewing sarcoma (3) hepatoblastoma (2) head and neck squamous cell carcinoma hnscc recurrent metastatic r m (1) nasopharyngeal carcinoma (1) lymphoepithelial carcinoma (1) medulloblastoma (1) atypical teratoid rhabdoid tumors (1) diffuse intrinsic pontine gliomas (1) other egfr positive pediatric solid tumors deemed eligible by the investigator (1) germ cell tumor (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology